{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:01:12Z","timestamp":1775545272625,"version":"3.50.1"},"reference-count":24,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMJ"],"DOI":"10.4274\/mmj.galenos.2024.60052","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T03:07:34Z","timestamp":1709176054000},"page":"0-0","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Different Doses of Sugammadex on Recovery and Hemodynamic Parameters in Reversing Neuromuscular Blockade in Patients Undergoing Electroconvulsive Therapy"],"prefix":"10.4274","author":[{"given":"Kadir","family":"ARSLAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gozde","family":"UCUKSARAC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hale","family":"CETIN ARSLAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkan","family":"AYDIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayca Sultan","family":"SAHIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/YCT.0000000000000187","article-title":"Electroconvulsive therapy-related cognitive impairment and choice of anesthesia: the tipping point","volume":"31","author":"Sedighinejad","year":"2015","unstructured":"1. Sedighinejad A, Nabi BN, Haghighi M, et al. Electroconvulsive therapy-related cognitive impairment and choice of anesthesia: the tipping point. J ECT. 2015;31:101-4.","journal-title":"J ECT"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1399-6576.2011.02520.x","article-title":"Neuromuscular blocking agents for electroconvulsive therapy: a systematic review","volume":"56","author":"Mirzakhani","year":"2012","unstructured":"2. Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand. 2012;56:3-16.","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jclinane.2008.06.006","article-title":"A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine","volume":"20","author":"Turkkal","year":"2008","unstructured":"3. Turkkal DC, Gokmen N, Yildiz A, et al. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine. J Clin Anesth. 2008;20:589-93.","journal-title":"J Clin Anesth"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcrc.2008.10.010","article-title":"Preclinical pharmacology of sugammadex","volume":"24","author":"Bom","year":"2009","unstructured":"4. Bom A, Hope F, Rutherford S, Thomson K. Preclinical pharmacology of sugammadex. J Crit Care. 2009;24:29-35.","journal-title":"J Crit Care"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/ACO.0b013e32814b1612","article-title":"Sugammadex: a novel neuromuscular blocker binding agent","volume":"20","author":"AM","year":"2007","unstructured":"5. Fields AM, Vadivelu N. Sugammadex: a novel neuromuscular blocker binding agent. Curr Opin Anaesthesiol. 2007;20:307-10.","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Karahan MA, B\u00fcy\u00fckf\u0131rat E, Binici O, et al. The The Effects of Rocuronium-sugammadex on Fetomaternal Outcomes in Pregnancy Undergoing Electroconvulsive Therapy: A Retrospective Case Series and Literature Review. Cureus. 2019;11:e4820.","DOI":"10.7759\/cureus.4820"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00540-011-1236-y","article-title":"Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy","volume":"25","author":"Kadoi","year":"2011","unstructured":"7. Kadoi Y, Hoshi H, Nishida A, Saito S. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy. J Anesth. 2011;25:855-9.","journal-title":"J Anesth"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. O\u0308zmen H, Ayd\u0131nl\u0131 B, Titiz L, Derici D. Comparing the Prevalence of Postoperative Complications in Groups of Patients Followed Up in the Recovery Room with and without the Use of the Modified Aldrete's Scoring System (MASS): A Retrospective Study. JARSS. 2020;28:188-93.","DOI":"10.5222\/jarss.2020.86548"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/acps.12721","article-title":"The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis","volume":"135","author":"T\u00f8rring","year":"2017","unstructured":"9. T\u00f8rring N, Sanghani SN, Petrides G, Kellner CH, \u00d8stergaard SD. The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis. Acta Psychiatr Scand. 2017;135:388-97.","journal-title":"Acta Psychiatr Scand"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1017\/S1092852900019003","article-title":"New developments in electroconvulsive therapy and magnetic seizure therapy","volume":"8","author":"Lisanby","year":"2003","unstructured":"10. Lisanby SH, Morales O, Payne N, et al. New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectr. 2003;8:529-36.","journal-title":"CNS Spectr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/YCT.0b013e318282d126","article-title":"Report on 3 years' experience in electroconvulsive therapy in bakirkoy research and training hospital for psychiatric and neurological diseases: 2008-2010","volume":"29","author":"Canbek","year":"2013","unstructured":"11. Canbek O, Menges OO, Atagun MI, Kutlar MT, Kurt E. Report on 3 years' experience in electroconvulsive therapy in bakirkoy research and training hospital for psychiatric and neurological diseases: 2008-2010. J ECT. 2013;29:51-7.","journal-title":"J ECT"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00127-008-0351-z","article-title":"Practice of electroconvulsive therapy at the research and training hospital in Turkey","volume":"43","author":"Saatcioglu","year":"2008","unstructured":"12. Saatcioglu O, Tomruk NB. Practice of electroconvulsive therapy at the research and training hospital in Turkey. Soc Psychiatry Psychiatr Epidemiol. 2008;43:673-7.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/ACO.0000000000000624","article-title":"Anesthesia for electroconvulsive therapy","volume":"31","author":"Soehle","year":"2018","unstructured":"13. Soehle M, Bochem J. Anesthesia for electroconvulsive therapy. Curr Opin Anaesthesiol. 2018;31:501-5.","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/01.yct.0000166633.73555.28","article-title":"Sevoflurane as an alternative anaesthetic for electroconvulsive therapy","volume":"21","author":"Toprak","year":"2005","unstructured":"14. Toprak HI, Gedik E, Bege\u00e7 Z, Ozt\u00fcrk E, Kaya B, Ersoy MO. Sevoflurane as an alternative anaesthetic for electroconvulsive therapy. J ECT. 2005;21:108-10.","journal-title":"J ECT"},{"key":"ref14","unstructured":"15. K\u0131l\u0131n\u00e7 G, Atik B, Mete A. Anesthesia in electroconvulsive therapy. Pamukkale Medical Journal. 2019;12:189-97."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1017\/neu.2017.12","article-title":"Anaesthesia for electroconvulsive therapy - new tricks for old drugs: a systematic review","volume":"30","author":"Stripp","year":"2018","unstructured":"16. Stripp TK, Jorgensen MB, Olsen NV. Anaesthesia for electroconvulsive therapy - new tricks for old drugs: a systematic review. Acta Neuropsychiatr. 2018;30:61-9.","journal-title":"Acta Neuropsychiatr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11126-016-9425-3","article-title":"Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey","volume":"87","author":"\u00d6zdemir","year":"2016","unstructured":"17. \u00d6zdemir A, Poyraz CA, Erten E, \u00c7\u0131rako\u011flu E, Tomruk N. Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey. Psychiatr Q. 2016;87:769-79.","journal-title":"Psychiatr Q"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. K\u00f6ksal E, \u00dcst\u00fcn YB, Kaya C, \u015eahin AR, \u015eahino\u011flu AH. Comparing the effects of rocuronium-sugammadex and succinylcholine on recovery during electroconvulsive therapy. Alpha Psychiatry. 2015;16:198-204.","DOI":"10.5455\/apd.170334"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Saricicek V, Sahin L, Bulbul F, Ucar S, Sahin M. Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression? J ECT. 2014;30:30-4.","DOI":"10.1097\/YCT.0b013e3182972bd2"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/YCT.0b013e318205e1d3","article-title":"Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency","volume":"27","author":"Batistaki","year":"2011","unstructured":"20. Batistaki C, Kesidis K, Apostolaki S, Kostopanagiotou G. Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency. J ECT. 2011;27:47-8.","journal-title":"J ECT"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Ta\u015f N, Demir EY. Rocuronium-Sugammadex in Anesthesia for Electroconvulsive Therapy.\u00a0Current Approaches in Psychiatry. 2015;8:76-84.","DOI":"10.18863\/pgy.91843"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/ija.IJA_132_17","article-title":"Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy","volume":"61","author":"PK","year":"2017","unstructured":"22. Kadiyala PK, Kadiyala LD. Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth. 2017;61:373-80.","journal-title":"Indian J Anaesth"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00540-011-1095-6","article-title":"Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy","volume":"25","author":"Hoshi","year":"2011","unstructured":"23. Hoshi H, Kadoi Y, Kamiyama J, et al. Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy. J Anesth. 2011;25:286-90.","journal-title":"J Anesth"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/YCT.0b013e3182887b5b","article-title":"Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option","volume":"29","author":"Tzabazis","year":"2013","unstructured":"24. Tzabazis A, Schmitt HJ, Ihmsen H, et al. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option. J ECT. 2013;29:189-95.","journal-title":"J ECT"}],"container-title":["Medeniyet Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:04:13Z","timestamp":1775541853000},"score":1,"resource":{"primary":{"URL":"https:\/\/medeniyetmedicaljournal.org\/articles\/doi\/MMJ.galenos.2024.60052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":24,"URL":"https:\/\/doi.org\/10.4274\/mmj.galenos.2024.60052","relation":{},"ISSN":["2149-2042"],"issn-type":[{"value":"2149-2042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}